Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the recipient of a large decline in short interest in July. As of July 31st, there was short interest totaling 593,731 shares, a decline of 57.3% from the July 15th total of 1,389,331 shares. Based on an average daily trading volume, of 417 shares, the short-interest ratio is currently 1,423.8 days.
Luye Pharma Group Price Performance
Shares of Luye Pharma Group stock remained flat at $0.27 during trading on Monday. The business’s 50 day moving average is $0.25 and its two-hundred day moving average is $0.32. Luye Pharma Group has a 12-month low of $0.20 and a 12-month high of $0.33.
Luye Pharma Group Company Profile
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Further Reading
- Five stocks we like better than Luye Pharma Group
- D-Wave Has Momentum—What Does It Need to Keep It Going?
- TSMC’s Insider Buying Wave Comes With a Bigger AI Question for Investors
- Looking Beyond CrowdStrike? 3 AI Security Stocks Stand Out
- 5 Recession-Proof Stocks Hiding in Cardboard Boxes
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
